Dr Ryder received his MD and PhD in Pharmacology from Case Western Reserve University School of Medicine. He completed a Residency in Clinical Pathology and Hematopathology Fellowship at University Hospitals Cleveland Medical Center/Case Western Reserve University. Dr Ryder joins us from University Hospitals Cleveland Medical Center/Case Western Reserve University, where he was, an Assistant Professor in the Department of Pathology. Dr Ryder's clinical interests include multimodal approaches to establish accurate diagnosis and prognostic stratification of myeloid malignancies by synthesizing morphological, immunophenotypic and genomic data. Dr Ryder has a background in the study of leukemia cell biology, with a focus on cell death pathways.